Literature DB >> 23423462

Tau and neuron aging.

Jesus Avila1, Elena Gomez de Barreda, Noemi Pallas-Bazarra, Felix Hernandez.   

Abstract

Tau protein could appear like a family of multiple isoforms rising by alternative splicing of its nuclear RNA or by different posttranslational modifications. The levels (or proportion) of these different tau isoforms could change in different neurons during development, aging or disease (tauopathies) in mammals. It is discussed that in some disorders there is a gain of toxic function of modified tau, due to the phosphorylation or aggregation of tau protein. These phenotypic changes are mainly found in aging organisms. On the other hand, loss of tau function could facilitate the appearance of some defects (related to iron toxicity) in aging animals lacking tau.

Entities:  

Keywords:  Alzheimer disease; Tau isoforms; posttranslational modifications

Year:  2012        PMID: 23423462      PMCID: PMC3570138     

Source DB:  PubMed          Journal:  Aging Dis        ISSN: 2152-5250            Impact factor:   6.745


  64 in total

1.  Characteristics and consequences of muscarinic receptor activation by tau protein.

Authors:  Alberto Gómez-Ramos; Miguel Díaz-Hernández; Alicia Rubio; Juan Ignacio Díaz-Hernández; Maria Teresa Miras-Portugal; Jesus Avila
Journal:  Eur Neuropsychopharmacol       Date:  2009-05-07       Impact factor: 4.600

2.  Tau protein diffuses along the microtubule lattice.

Authors:  Maike H Hinrichs; Avesta Jalal; Bernhard Brenner; Eckhard Mandelkow; Satish Kumar; Tim Scholz
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

3.  Function of tau protein in adult newborn neurons.

Authors:  Almudena Fuster-Matanzo; Elena Gómez de Barreda; Hana N Dawson; Michael P Vitek; Jesús Avila; Félix Hernández
Journal:  FEBS Lett       Date:  2009-08-18       Impact factor: 4.124

4.  Propagation of tau misfolding from the outside to the inside of a cell.

Authors:  Bess Frost; Rachel L Jacks; Marc I Diamond
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

5.  Tau--an inhibitor of deacetylase HDAC6 function.

Authors:  Mar Perez; Ismael Santa-Maria; Elena Gomez de Barreda; Xiongwei Zhu; Raquel Cuadros; Jose Roman Cabrero; Francisco Sanchez-Madrid; Hana N Dawson; Michael P Vitek; George Perry; Mark A Smith; Jesus Avila
Journal:  J Neurochem       Date:  2009-05-07       Impact factor: 5.372

6.  Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling.

Authors:  Margaret H Magdesian; Milena M V F Carvalho; Fabio A Mendes; Leonardo M Saraiva; Maria A Juliano; Luiz Juliano; José Garcia-Abreu; Sérgio T Ferreira
Journal:  J Biol Chem       Date:  2008-01-30       Impact factor: 5.157

7.  Histone deacetylase 6 interacts with the microtubule-associated protein tau.

Authors:  Huiping Ding; Philip J Dolan; Gail V W Johnson
Journal:  J Neurochem       Date:  2008-07-12       Impact factor: 5.372

Review 8.  Tau phosphorylation: the therapeutic challenge for neurodegenerative disease.

Authors:  Diane P Hanger; Brian H Anderton; Wendy Noble
Journal:  Trends Mol Med       Date:  2009-02-24       Impact factor: 11.951

9.  Transmission and spreading of tauopathy in transgenic mouse brain.

Authors:  Florence Clavaguera; Tristan Bolmont; R Anthony Crowther; Dorothee Abramowski; Stephan Frank; Alphonse Probst; Graham Fraser; Anna K Stalder; Martin Beibel; Matthias Staufenbiel; Mathias Jucker; Michel Goedert; Markus Tolnay
Journal:  Nat Cell Biol       Date:  2009-06-07       Impact factor: 28.824

Review 10.  Chaperone signalling complexes in Alzheimer's disease.

Authors:  John Koren; Umesh K Jinwal; Daniel C Lee; Jeffrey R Jones; Cody L Shults; Amelia G Johnson; Laura J Anderson; Chad A Dickey
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

View more
  7 in total

Review 1.  Life and death in the trash heap: The ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia.

Authors:  Steven H Graham; Hao Liu
Journal:  Ageing Res Rev       Date:  2016-10-01       Impact factor: 10.895

Review 2.  Targeting the mTOR signaling network for Alzheimer's disease therapy.

Authors:  Chong Wang; Jin-Tai Yu; Dan Miao; Zhong-Chen Wu; Meng-Shan Tan; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-07-14       Impact factor: 5.590

3.  Rapamycin suppresses brain aging in senescence-accelerated OXYS rats.

Authors:  Nataliya G Kolosova; Anton O Vitovtov; Natalia A Muraleva; Andrey E Akulov; Natalia A Stefanova; Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2013-06       Impact factor: 5.682

4.  Global axonal transport rates are unaltered in htau mice in vivo.

Authors:  Aidong Yuan; Asok Kumar; Takahiro Sasaki; Karen Duff; Ralph A Nixon
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 5.  Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins.

Authors:  Jesús Avila; María Llorens-Martín; Noemí Pallas-Bazarra; Marta Bolós; Juan R Perea; Alberto Rodríguez-Matellán; Félix Hernández
Journal:  Front Neurosci       Date:  2017-11-10       Impact factor: 4.677

6.  Brains of rhesus monkeys display Aβ deposits and glial pathology while lacking Aβ dimers and other Alzheimer's pathologies.

Authors:  Jing Zhang; Baian Chen; Jing Lu; Yi Wu; Shubo Wang; Zitong Yao; Liming Zhu; Yanhua Qiao; Quan Sun; Wei Qin; Qiao Zhao; Jianping Jia; Cuibai Wei
Journal:  Aging Cell       Date:  2019-06-04       Impact factor: 9.304

Review 7.  The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD).

Authors:  Barbara Mroczko; Magdalena Groblewska; Ala Litman-Zawadzka
Journal:  Int J Mol Sci       Date:  2019-09-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.